Big Pharma's March Into Biotech Could Make Big Biologics A Big '09 Theme
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
In 2009, some of the biggest new drugs might not technically be drugs at all. Major biologic products could dominate the upcoming year, largely thanks to big pharma's maturing interest in biotechnology